• Home
  • |
  • Organization
  • |
  • Contacts
  • |
  • Pharmacovigilance
  • |
  • Chiesi Group world.png
  • SE
  • EN
Welcome to Chiesi
SVERIGE
Enter at least 3 characters
MENU
  • About us
    • Our company
    • Organization
    • Our history
    • Chiesi globally
    • Mission And Values
    • Compliance
    • Our B Corp certification
    • Annual & sustainability report
  • Therapeutic areas
    • General
    • Respiratory
    • Neonatology
    • Rare diseases
    • Special care
  • Research and development
    • Pipeline
    • Production plants
  • Sustainability
    • Sustainability at Chiesi
    • How Chiesi work with sustainability
    • We Act
    • Community
    • Chiesi Pharma's sustainability goals
    • Summary annual and sustainability report 2020
    • Summary of Nordic Sustainability actions 2020
    • SpeakUp&BeHeard
  • Working at Chiesi
    • Our Commitment
    • Developing our People
    • Join our team
    • Meet Our People
  • Media
    • News and press release
  • Sustainability in Chiesi
  • HOW CHIESI WORK WITH SUSTAINABILITY
  • NEONATOLOGY
  • RARE DISEASES
  • RESPIRATORY DISEASES
  • SPECIAL CARE
  • icon_polmoini_B.png
    Respiratory
    Chiesi conducts research within asthma and COPD, the most...
    btnaree.png
    icon_polmoini_B.png
    Respiratory
    Chiesi conducts research within asthma and COPD, the most...
    btnaree.png
  • icon_neonato_B.png
    Neonatology
    CHIESI – A RESULT OF SUCCESSFUL...
    btnaree.png
    icon_neonato_B.png
    Neonatology
    CHIESI – A RESULT OF SUCCESSFUL...
    btnaree.png
  • icon_malattierare_B.png
    Rare diseases
    RARE DISEASES Rare diseases, or uncommon...
    btnaree.png
    icon_malattierare_B.png
    Rare diseases
    RARE DISEASES Rare diseases, or uncommon...
    btnaree.png
  • ic_sp_ca_off.png
    Special care
    Kidney and liver failure – organ...
    btnaree.png
    ic_sp_ca_off.png
    Special care
    Kidney and liver failure – organ...
    btnaree.png
Chiesi är en av Sveriges bästa arbetsplatser btnricerca.png
Chiesi outlines €350 million investment and... btnricerca.png
PUBLICATIONS
12_86_2020_07_15_chiesi_sustainability_report_ita_print-1.jpg
2021
Annual &...
download.png Download PDF
version
Other publications plus.png
© 2023 Chiesi Pharma AB
Klara Norra kyrkogata 34, 111 22 Stockholm
Telefon +46 8 753 35 20
E-post infonordic@chiesi.com

R&D, Global Rare Diseases
Chiesi Pharma AB, Scheeles väg 2, 171 65 Solna
Telefon + 46 8 753 35 20

Updated at 21/01/2022
  • Sitemap
  • Cookies
  • Credits
  • Credits
  • Privacy policy
  • SpeakUp&BeHeard
CHIESI ON THE WEB
mappa.png
CHIESI ON THE WEB
Austria
Chiesi Pharmaceuticals GmbH
Belgium
Chiesi sa
Brazil
Chiesi Farmacêutica Ltda
Bulgaria
Chiesi Bulgaria Ltd.
China
Chiesi Pharmaceutical (Shanghai) Co., Ltd
Czech Republic
Chiesi CZ s.r.o.
Germany
Chiesi GmbH
Greece
Chiesi Hellas Pharmaceuticals S.A.
Hungary
Chiesi Hungary Kft.
Italy
-
Mexico
Chiesi Mexico S.A. de C.V.
Pakistan
Chiesi Pharmaceuticals (Pvt) Limited
Poland
Chiesi Polonia
Romania
Chiesi România S.r.l.
Russian Federation
Chiesi Pharmaceuticals LLC
Scandinavia
Chiesi Pharma AB
Slovak Republic
Chiesi Slovakia s.r.o
Slovenia
Chiesi Slovenija, d.o.o
Spain
Chiesi España S.A.
The Netherlands
Chiesi Pharmaceuticals B.V.
Turkey
Chiesi İlaçTicaret Limited Sirketi  A.Ş.
United Kingdom
Chiesi Ltd
United States
Chiesi Usa Inc.